Active component of Danshen (Salvia miltiorrhiza Bunge), Tanshinone I, attenuates lung tumorigenesis via inhibitions of VEGF, Cyclin A, and Cyclin B expressions

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Tung, Yu Tang ^a   Chen, Hsiao Ling ^b   Lee, Cheng Yu ^c   Chou, Yu Ching ^a   Lee, Po Ying ^d   Tsai, Hsin Chung ^a,e   Lin, Yi Ling ^a,f   Chen, Chuan Mu ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b DA YEH UNIVERSITY   (Taiwan)

^c NATIONAL PINGTUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e TAICHUNG HOSPITAL   (Taiwan)

^f TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; CYCLIN B; PLACEBO; RECOMBINANT VASCULAR ENDOTHELIAL GROWTH FACTOR A 165; RECOMBINANT VASCULOTROPIN; TANSHINONE I; TANSHINONE IIA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; ATTENUATION; CANCER CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CHEMICAL COMPOSITION; CONDITIONED MEDIUM; CONTROLLED STUDY; CULTURE MEDIUM; DRUG EFFICACY; FEMALE; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LEUKEMIA CELL; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG CARCINOGENESIS; LUNG TUMOR; MALE; MONOCYTIC LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SALVIA MILTIORRHIZA; TRANSGENIC MOUSE; TUMOR CELL LINE; TUMOR XENOGRAFT;

EID: 84877297545     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/319247     Document Type: Article

References (37)

1. Ko Y. C., Lee C. H., Chen M. J., Risk factors for primary lung cancer among non-smoking women in Taiwan. International Journal of Epidemiology 1997 26 24 31
2. Martinez-Moreno P., Nieto-Ceron S., Torres-Lanzas J., Cholinesterase activity of human lung tumours varies according to their histological classification. Cancinogensis 2005 27 429 436 (Pubitemid 43372872)
3. Minna J. D., Roth J. A., Gazdar A. F., Focus on lung cancer. Cancer Cell 2002 1 49 52 (Pubitemid 41039175)
4. Lin S. S., Lai K. C., Hsu S. C., Yang J. S., Kuo C. L., Lin J. P., Ma Y. S., Wu C. C., Chung J. G., Curcumin inhibits the migration and invasion of human A549 lung cancer cells through the inhibition of matrix metalloproteinase-2 and -9 and Vascular Endothelial Growth Factor (VEGF). Cancer Letters 2009 285 2 127 133 2-s2.0-70349970838 10.1016/j.canlet.2009.04.037
5. Gasparini G., The rationale and future potential of angiogenesis inhibitors in neoplasia. Drugs 1999 58 1 17 38 2-s2.0-0032792360 10.2165/00003495-199958010-00003 (Pubitemid 29373884)
6. Ferrara N., VEGF and the request for tumor angiogenesis factors. Nature Review Cancer 2002 2 795 803 (Pubitemid 37328914)
7. Ferrara N., Davis-Smyth T., The biology of vascular endothelial growth factor. Endocrine Reviews 1997 18 1 4 25 2-s2.0-0031039243 10.1210/er.18.1.4 (Pubitemid 27076453)
8. Gong Y., Li Y., Lu Y., Li L., Abdolmaleky H., Blackburn G. L., Zhou J. R., Bioactive tanshinones in Salvia miltiorrhiza inhibit the growth of prostate cancer cells in vitro and in mice. International Journal of Cancer 2011 129 5 1042 1052 2-s2.0-79959767855 10.1002/ijc.25678
9. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630 (Pubitemid 41643896)
10. Xia Z., Gu J., Ansley D. M., Xia F., Yu J., Antioxidant therapy with Salvia miltiorrhiza decreases plasma endothelin-1 and thromboxane B2 after cardiopulmonary bypass in patients with congenital heart disease. Journal of Thoracic and Cardiovascular Surgery 2003 126 5 1404 1410 2-s2.0-0344494039 10.1016/S0022-5223(03)00970-X (Pubitemid 37449166)
11. Wang X., Morris-Natschke S. L., Lee K. H., New developments in the chemistry and biology of the bioactive constituents of Tanshen. Medicinal Research Reviews 2007 27 1 133 148 2-s2.0-33845768814 10.1002/med.20077 (Pubitemid 44975189)
12. Wu W. L., Chang W. L., Chen C. F., Cytotoxic activities of tanshinones against human carcinoma cell lines. American Journal of Chinese Medicine 1991 19 3-4 207 216 2-s2.0-0026309074
13. Mosaddik M. A., In vitro cytotoxicity of Tanshinones isolated from Salvia miltiorrhiza Bunge against P388 lymphocytic leukemia cells. Phytomedicine 2003 10 8 682 685 2-s2.0-0344197546 10.1078/0944-7113-00321 (Pubitemid 37500097)
14. Song Y., Yuan S. L., Yang Y. M., Wang X. J., Huang G. Q., Alteration of activities of telomerase in tanshinone IIA inducing apoptosis of the leukemia cells. Zhongguo Zhongyao Zazhi 2005 30 3 207 211 2-s2.0-21444433926 (Pubitemid 44366792)
15. Sung H. J., Choi S. M., Yoon Y., An K. S., Tanshinone IIA, an ingredient of Salvia miltiorrhiza BUNGE, induces apoptosis in human leukemia cell lines through the activation of caspase-3. Experimental and Molecular Medicine 1999 31 4 174 178 2-s2.0-0033621456 (Pubitemid 30021333)
16. Yoon Y., Kim Y. O., Jeon W. K., Park H. J., Sung H. J., Tanshinone IIA isolated from Salvia miltiorrhiza BUNGE induced apoptosis in HL60 human premyelocytic leukemia cell line. Journal of Ethnopharmacology 1999 68 1-3 121 127 2-s2.0-0032720014 10.1016/S0378-8741(99)00059-8 (Pubitemid 29502468)
17. Lee C. Y., Sher H. F., Chen H. W., Anticancer effects of tanshinone I in human non-small cell lung cancer. Molecular Cancer Therapeutics 2008 7 3527 3538
18. Nizamutdinova I. T., Lee G. W., Lee J. S., Cho M. K., Son K. H., Jeon S. J., Kang S. S., Kim Y. S., Lee J. H., Seo H. G., Chang K. C., Kim H. J., Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 2008 29 10 1885 1892 2-s2.0-53349127298 10.1093/carcin/bgn151
19. Coussens L. M., Werb Z., Inflammation and cancer. Nature 2002 420 6917 860 867 2-s2.0-0037180757 10.1038/nature01322 (Pubitemid 36019639)
20. Chen J. J. W., Yao P. L., Yuan A., Hong T. M., Shun C. T., Kuo M. L., Lee Y. C., Yang P. C., Up-regulation of tumor interleukin-8 expression by infiltrating macrophages: its correlation with tumor angiogenesis and patient survival in non-small cell lung cancer. Clinical Cancer Research 2003 9 2 729 737 2-s2.0-0037314662 (Pubitemid 36182607)
21. Opal S. M., DePalo V. A., Anti-inflammatory cytokines. Chest 2000 117 4 1162 1172 2-s2.0-0034090602 (Pubitemid 30228378)
22. Yao P. L., Tsai M. F., Lin Y. C., Wang C. H., Liao W. Y., Chen J. J. W., Yang P. C., Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respiratory Research 2005 6, article 89 2-s2.0-26244453996 10.1186/1465-9921-6-89 (Pubitemid 41410148)
23. Yuan D., Pan Y. N., Fu W. W., Makino T., Kano Y., Quantitative analysis of the marker compounds in Salvia miltiorrihiza root and its phytomedicinal preparations. Chemical and Pharmaceutical Bulletin 2005 53 5 508 514 2-s2.0-19644384525 10.1248/cpb.53.508 (Pubitemid 40740618)
24. Chen J. J. W., Lin Y. C., Yao P. L., Tumor-associated macrophages: the double-edged sword in cancer progression. Journal of Clinical Oncology 2005 23 953 964 (Pubitemid 46202315)
25. Tung Y. T., Chen H. L., Lai C. W., Shen C. J., Lai Y. W., Chen C. M., Curcumin reduces pulmonary tumorigenesis in vascular endothelial growth factor (VEGF)-overexpressing transgenic mice. Molecular Nutrition and Food Research 2011 55 7 1036 1043 2-s2.0-79959964907 10.1002/mnfr.201000654
26. Yen C. C., Lin C. Y., Chong K. Y., Tsai T. C., Shen C. J., Lin M. F., Su C. Y., Chen H. L., Chen C. M., Lactoferrin as a natural regimen for selective decontamination of the digestive tract: recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonates from pathogenic challenge in the gastrointestinal tract. Journal of Infectious Diseases 2009 199 4 590 598 2-s2.0-61849184878 10.1086/596212
27. Chen Y. J., Wu C. Y., Chang C. C., Nuclear Kruppel-like factor 4 expression is associated with human skin squamous cell carcinoma progression and metastasis. Cancer Biology and Therapy 2008 7 777 782
28. Chen H. L., Wang L. C., Chang C. H., Yen C. C., Cheng W. T. K., Wu S. C., Hung C. M., Kuo M. F., Chen C. M., Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine 2008 26 7 891 898 2-s2.0-38649115675 10.1016/j.vaccine.2007.12.013
29. Chen H. L., Lai Y. W., Chen C. S., Chu T. W., Lin W., Yen C. C., Lin M. F., Tu M. Y., Chen C. M., Probiotic lactobacillus casei expressing human lactoferrin elevates antibacterial activity in the gastrointestinal tract. BioMetals 2010 23 3 543 554 2-s2.0-77953289731 10.1007/s10534-010-9298-0
30. Tsai T. C., Lin W., Yang S. H., Cheng W. T. K., Cheng E. H., Lee M. S., Chong K. Y., Chen C. M., Granzyme G is expressed in the two-cell stage mouse embryo and is required for the maternal-zygotic transition. BMC Developmental Biology 2010 10, article 88 2-s2.0-77955357323 10.1186/1471-213X-10-88
31. Chen Y. J., Wu C. Y., Shen J. L., Chu S. Y., Chen C. K., Chang Y. T., Chen C. M., Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome. Archives of Dermatology 2008 144 12 1571 1575 2-s2.0-58049198305 10.1001/archderm.144.12.1571
32. Wu S. C., Chen H. L., Yen C. C., Kuo M. F., Yang T. S., Wang S. R., Weng C. N., Chen C. M., Cheng W. T. K., Recombinant porcine lactoferrin expressed in the milk of transgenic mice enhances offspring growth performance. Journal of Agricultural and Food Chemistry 2007 55 12 4670 4677 2-s2.0-34250744578 10.1021/jf063759o (Pubitemid 46960891)
33. Ryu S. Y., Lee C. O., Choi S. U., In vitro cytotoxicity of tanshinones from Salvia miltiorrhiza. Planta Medica 1997 63 4 339 342 2-s2.0-0030810489 10.1055/s-2006-957696 (Pubitemid 27322428)
34. Nizamutdinova I. T., Lee G. W., Lee J. S., Tanshinone I suppresses growth and invasion of human breast cancer cells, MDA-MB-231, through regulation of adhesion molecules. Carcinogenesis 2008 29 1885 1892
35. Eberly L. E., Ockene J., Sherwin R., Yang L., Kuller L., Pulmonary function as a predictor of lung cancer mortality in continuing cigarette smokers and in quitters. International Journal of Epidemiology 2003 32 4 592 599 2-s2.0-0041883806 10.1093/ije/dyg177 (Pubitemid 37039014)
36. Nizamutdinova I. T., Lee G. W., Son K. H., Jeon S. J., Kang S. S., Kim Y. S., Lee J. H., Seo H. G., Chang K. C., Kim H. J., Tanshinone I effectively induces apoptosis in estrogen receptor-positive (MCF-7) and estrogen receptor-negative (MDA-MB-231) breast cancer cells. International Journal of Oncology 2008 33 3 485 491 2-s2.0-54849187400 10.3892/ijo-00000031
37. Shyur L. F., Lee S. H., Chang S. T., Lo C. P., Kuo Y. H., Wang S. Y., Taiwanin A inhibits MCF-7 cancer cell activity through induction of oxidative stress, upregulation of DNA damage checkpoint kinases, and activation of p53 and FasL/Fas signaling pathways. Phytomedicine 2010 18 1 16 24 2-s2.0-78649792131 10.1016/j.phymed.2010.06.005